In the MSARD group, median values of CSF CD25 (Figure S3A) were higher in MS (20.5 (IQR 16.3) pg/ml) than in CIS patients (14.6 (IQR 11.4) pg/ml), p = 0.023. The gene discussed is IL2RA; the disease is in situ carcinoma.